...
search icon
pbm-img

Psyence Biomedical Ltd. Common Shares, Common Stock

PBM

NAQ

$1.7

-$0.14

(-7.61%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$7.53M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
106.21K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.36
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.51 L
$945.15 H
$1.7

About Psyence Biomedical Ltd. Common Shares, Common Stock

Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc. more

Industry: BiotechnologySector: Health Care

Returns

Time FramePBMSectorS&P500
1-Week Return-15.84%0.49%-0.42%
1-Month Return-17.87%-3.1%-2.2%
3-Month Return-75.09%-8.59%2.38%
6-Month Return-92.89%-4.57%5.1%
1-Year Return-99.8%-0.94%23.79%
3-Year Return-99.77%2.88%26.66%
5-Year Return-99.77%35.84%81.16%

Financials

Mar '22Mar '23Mar '24
Total Revenue---[{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Cost of Revenue--240.00[{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Gross Profit--(240.00)[{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":-24000,"profit":false}]
Gross Margin--(Infinity%)[{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":null,"profit":false}]
Operating Expenses334.29K1.29M2.75M[{"date":"2022-03-31","value":12.15,"profit":true},{"date":"2023-03-31","value":47.03,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Operating Income(334.29K)(1.29M)(2.75M)[{"date":"2022-03-31","value":-33429000,"profit":false},{"date":"2023-03-31","value":-129398000,"profit":false},{"date":"2024-03-31","value":-275182500,"profit":false}]
Total Non-Operating Income/Expense8.56M9.31M(48.46M)[{"date":"2022-03-31","value":92,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":-520.5,"profit":false}]
Pre-Tax Income8.23M8.01M(51.16M)[{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":97.37,"profit":true},{"date":"2024-03-31","value":-621.58,"profit":false}]
Income Taxes---[{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Income After Taxes---[{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Income From Continuous Operations(1.86M)(3.21M)(51.16M)[{"date":"2022-03-31","value":-185823495,"profit":false},{"date":"2023-03-31","value":-320640300,"profit":false},{"date":"2024-03-31","value":-5115904700,"profit":false}]
Income From Discontinued Operations---[{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Net Income8.23M8.01M(51.16M)[{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":97.37,"profit":true},{"date":"2024-03-31","value":-621.58,"profit":false}]
EPS (Diluted)26.8312.39-[{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":46.19,"profit":true},{"date":"2024-03-31","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

PBM
Cash Ratio 0.06
Current Ratio 0.09

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PBM
ROA (LTM) -126.35%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PBM
Debt Ratio Lower is generally better. Negative is bad. 10.69
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -9.69

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PBM
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.00
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Psyence Biomedical Ltd. Common Shares share price today?

Psyence Biomedical Ltd. Common Shares (PBM) share price today is $1.7

Can Indians buy Psyence Biomedical Ltd. Common Shares shares?

Yes, Indians can buy shares of Psyence Biomedical Ltd. Common Shares (PBM) on Vested. To buy Psyence Biomedical Ltd. Common Shares from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PBM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Psyence Biomedical Ltd. Common Shares be purchased?

Yes, you can purchase fractional shares of Psyence Biomedical Ltd. Common Shares (PBM) via the Vested app. You can start investing in Psyence Biomedical Ltd. Common Shares (PBM) with a minimum investment of $1.

How to invest in Psyence Biomedical Ltd. Common Shares shares from India?

You can invest in shares of Psyence Biomedical Ltd. Common Shares (PBM) via Vested in three simple steps:

  • Click on Sign Up or Invest in PBM stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Psyence Biomedical Ltd. Common Shares shares
What is Psyence Biomedical Ltd. Common Shares 52-week high and low stock price?

The 52-week high price of Psyence Biomedical Ltd. Common Shares (PBM) is $945.15. The 52-week low price of Psyence Biomedical Ltd. Common Shares (PBM) is $1.51.

What is Psyence Biomedical Ltd. Common Shares price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Psyence Biomedical Ltd. Common Shares (PBM) is

What is Psyence Biomedical Ltd. Common Shares price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Psyence Biomedical Ltd. Common Shares (PBM) is 0.00

What is Psyence Biomedical Ltd. Common Shares dividend yield?

The dividend yield of Psyence Biomedical Ltd. Common Shares (PBM) is 0.00%

What is the Market Cap of Psyence Biomedical Ltd. Common Shares?

The market capitalization of Psyence Biomedical Ltd. Common Shares (PBM) is $7.53M

What is Psyence Biomedical Ltd. Common Shares’s stock symbol?

The stock symbol (or ticker) of Psyence Biomedical Ltd. Common Shares is PBM

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top